首页> 外文OA文献 >Pharmacokinetics and pharmacodynamics of Ro 44–3888 after single ascending oral doses of sibrafiban, an oral platelet aggregation inhibitor, in healthy male volunteers

【2h】

Pharmacokinetics and pharmacodynamics of Ro 44–3888 after single ascending oral doses of sibrafiban, an oral platelet aggregation inhibitor, in healthy male volunteers

机译：Ro 44–3888在健康男性志愿者中单次递增口服剂量的口服血小板聚集抑制剂sibrafiban的药代动力学和药效学

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Wittke, Bärbel; Mackie, Ian J; Machin, Samuel J; Timm, Uwe; Zell, Manfred; Goggin, Timothy;
展开▼
作者单位

展开▼
年度 2001
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Pharmacokinetics and pharmacodynamics of Ro 44-3888 after single ascending oral doses of sibrafiban, an oral platelet aggregation inhibitor, in healthy male volunteers. [J] . Wittke B, Mackie IJ, Machin SJ, British Journal of Clinical Pharmacology . 1999,第5期

机译：Ro 44-3888在健康男性志愿者中单次递增口服剂量的口服血小板聚集抑制剂sibrafiban的药代动力学和药效学。
2. Safety, Pharmacokinetics, and Pharmacodynamics of ME-401, an Oral, Potent, and Selective Inhibitor of Phosphatidylinositol 3-Kinase P110 delta, Following Single Ascending Dose Administration to Healthy Volunteers [J] . Moreno Ofir, Butler Todd, Zann Vanessa, Clinical therapeutics . 2018,第11期

机译：ME-401的安全性，药代动力学和药效学和磷脂酰肌醇3-激酶P110δ的口服，有效和选择性抑制剂，其单一升序剂量给予健康志愿者
3. Crossover dose escalation study to assess safety, pharmacokinetics, and pharmacodynamics of single doses of R1663, an oral factor Xa inhibitor, in healthy male volunteers [J] . SchmittC., PannierA., McIntyreC., The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology . 2012,第4期

机译：交叉剂量递增研究评估了健康男性志愿者中单剂量口服口服Xa抑制剂R1663的安全性，药代动力学和药效学
4. Interaction of subcutaneous lixisenatide 20 μg QD on pharmacokinetic and pharmacodynamic properties of oral ramipril 5 mg QD in steady state in young healthy males and females [C] . Dahmen R, Steinstraesser A, Poitiers F, European Association for Clinical Pharmacology and Therapeutics . 2011

机译：皮下丽西齐肽的相互作用20μgQD对年轻健康男性稳态口腔ramipril 5mg qd的药代动力学和药物动力学性质
5. Development of novel spray coated soft elastic gelatin capsule sustained release formulations of nifedipine, bioavailability and bioequivalence of verapamil HCL controlled release formulations, pharmacokinetics of terbinafine after single oral doses in raptors. [D] . Fahmy, Sahar Abd El-Sattar. 2004

机译：硝苯地平新型喷雾包衣的软弹性明胶胶囊缓释制剂的开发，维拉帕米盐酸盐控释制剂的生物利用度和生物等效性，在猛禽中单次口服剂量后特比萘芬的药代动力学。
6. Pharmacokinetics and pharmacodynamics of Ro 44–3888 after single ascending oral doses of sibrafiban an oral platelet aggregation inhibitor in healthy male volunteers [O] . Bärbel Wittke, Ian J Mackie, Samuel J Machin, 1999

机译：Ro 44–3888在健康男性志愿者中单次递增口服剂量的口服血小板聚集抑制剂sibrafiban的药代动力学和药效学
7. Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of Bi 187004, an Inhibitor of 11beta-hydroxysteroid Dehydrogenase-1, in Healthy Male Volunteers With Overweight or Obesity [O] . Susanna Bianzano, Tim Heise, Arvid Jungnik, 2020

机译：单次口服剂量，乳头剂量的安全性，耐受性，药代动力学和药效学，11beta-羟类脱氢酶-1的抑制剂，具有超重或肥胖的健康男性志愿者

Pharmacokinetics and pharmacodynamics of Ro 44–3888 after single ascending oral doses of sibrafiban, an oral platelet aggregation inhibitor, in healthy male volunteers

著录项

引文网络

相似文献

相关主题

期刊订阅